consequences of glp 1 Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds Long-Term Effects Of GLP-1 Medications:

Rein DB et al

What has been slower to emerge is a framework that recognizes these not as independent problems but as coordinated consequences of a single underlying disruption: the withdrawal of hormonal signals that had, for decades, been quietly governing cellular energy regulation, inflammatory tone, and tissue maintenance throughout the body

The safety of concomitantly administered empagliflozin (daily dosage 10 mg or 25 mg) and metformin HCl (mean daily dosage of approximately 1,800 mg) has been evaluated in 3,456 adult patients with type 2 diabetes mellitus treated for 16 to 24 weeks, of which 926 patients received placebo, 1,271 patients received a daily dosage of empagliflozin 10 mg, and 1,259 patients received a daily dosage of empagliflozin 25 mg

Additionally, the company notes its medication can lower glucagon secretion and causes a delay in gastric emptying

Published Feb 17, 2025

TL;DR GLP-1 patches (including Kind Patches, Gentle Patches, Patched GLP-1, Oceaura, and Ledisa) are over-the-counter adhesive skin patches marketed for weight management